Cibus is an agricultural biotechnology company developing precision gene-edited plant traits using non-GMO gene editing technology (RTDS including TALEN and GRON). The company licenses gene-edited crop traits to seed companies for royalties, focusing on weed management, herbicide tolerance, and disease resistance in crops including rice, canola, and soybean. Following the June 2023 merger with Calyxt, Cibus operates as a public company (NASDAQ: CBUS) with over 1,000 issued or pending patents in gene editing for agriculture.
Cibus is publicly traded
This company is no longer available on our private secondary market. Shares can be traded publicly under its listed ticker.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2001
Employees
100-250
Total Funding
$216M
3 rounds
Total raised $216M across 3 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 05-08-2026
Latest Round
Type
Public Offering
Date
March 2024
Amount
$27.5M
Valuation
—
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| March 2024 | Public Offering | $27.5M | — | |
| June 1, 2023 | Series F (Private Units) | $118.5M | — | |
| June 26, 2018 | Series C | $70M | — | Fidelity Management and Research Company |
Peter Beetham
Interim Chief Executive Officer, President & Chief Operating Officer
Rory Riggs
Chairman of the Board of Directors
Greg Gocal
Co-Founder & Chief Scientific Officer & EVP
James Radtke
SVP, Product Development
Noel Sauer
SVP, Research
Rosa Cheuk Kim
SVP, Legal
Cibus merged with Calyxt via SPAC transaction, with combined company beginning public trading on NASDAQ Capital Market under ticker CBUS on June 1, 2023. The company remains public and filed 10-K annual report in March 2025.
Cibus shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker to place an order.
Cibus raised $216M across 3 disclosed funding rounds prior to its public listing.
Cibus was founded by Greg Gocal in 2001.
Cibus is headquartered in San Diego, California.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.